Simultaneous Runs of the Bayer VERSANT HIV-1 Version 3.0 and HCV bDNA Version 3.0 Quantitative Assays on the System 340 Platform Provide Reliable Quantitation and Improved Work Flow

Documenti analoghi

• Multicenter Evaluation of the Performance Characteristics of the Bayer VERSANT HCV RNA 3.0 Assay (bDNA)
  di: Elbeik, Tarek, et al.
  Pubblicazione: (2004)
• Quantitative and Cost Comparison of Ultrasensitive Human Immunodeficiency Virus Type 1 RNA Viral Load Assays: Bayer bDNA Quantiplex Versions 3.0 and 2.0 and Roche PCR Amplicor Monitor Version 1.5
  di: Elbeik, Tarek, et al.
  Pubblicazione: (2000)
• Evaluation of the VACUTAINER PPT Plasma Preparation Tube for Use with the Bayer VERSANT Assay for Quantification of Human Immunodeficiency Virus Type 1 RNA
  di: Elbeik, Tarek, et al.
  Pubblicazione: (2005)
• Use of versant™ TMA and bDNA 3.0 assays to detect and quantify hepatitis C virus in semen
  di: Pekler, Vyacheslav A., et al.
  Pubblicazione: (2003)
• Performance of the New Bayer VERSANT HCV RNA 3.0 Assay for Quantitation of Hepatitis C Virus RNA in Plasma and Serum: Conversion to International Units and Comparison with the Roche COBAS Amplicor HCV Monitor, Version 2.0, Assay
  di: Beld, Marcel, et al.
  Pubblicazione: (2002)